For Quick Alerts
For Daily Alerts

Dr Reddy's Labs introduces Sildenafil Tablets in US

By Religare

Hyderabad-based pharmaceutical giant Dr. Reddy's Laboratories Ltd today said that it has introduced Sildenafil Tablets (20 mg), which is a bioequivalent generic version of REVATIO® tablets, in the US.

The company has introduced the tablets after receiving the required approval by the United States Food & Drug Administration, said the company in its filing to the Bombay Stock Exchange.

Offered in 90 count bottle sizes, the Sildenafil tablets (20 mg) are used to treat erectile dysfunction and pulmonary arterial hypertension (PAH), the filing added.

Read more about: dr reddys laboratories
Story first published: Monday, November 19, 2012, 21:30 [IST]
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more